VIP and cancer: Carnitine and acetylcarnitine were significantly upregulated in cancer compared to NCE (VIP ≥ 1.93, p < 0.001, Fig. 2d, Fig. 3, and Table 1), in addition to borderline significant higher levels compared to stroma (VIP = 1.26, p ≤ 0.076, Fig. 2f).